These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28507200)

  • 21. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
    Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
    Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
    Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
    Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyanobacterial lectins characteristics and their role as antiviral agents.
    Singh RS; Walia AK; Khattar JS; Singh DP; Kennedy JF
    Int J Biol Macromol; 2017 Sep; 102():475-496. PubMed ID: 28437766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
    Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus entry.
    Zeisel MB; Felmlee DJ; Baumert TF
    Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of peptides that bind hepatitis C virus envelope protein E2 and inhibit viral cellular entry from a phage-display peptide library.
    Lü X; Yao M; Zhang JM; Yang J; Lei YF; Huang XJ; Jia ZS; Ma L; Lan HY; Xu ZK; Yin W
    Int J Mol Med; 2014 May; 33(5):1312-8. PubMed ID: 24573486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Structure and Function of a Novel Class of High Mannose-binding Proteins with Anti-viral or Anti-tumor Activity].
    Sato Y
    Yakugaku Zasshi; 2015; 135(11):1281-9. PubMed ID: 26521877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel thioglycosyl analogs of glycosyltransferase substrates as antiviral compounds against classical swine fever virus and hepatitis C virus.
    Pastuch-Gawolek G; Chaubey B; Szewczyk B; Krol E
    Eur J Med Chem; 2017 Sep; 137():247-262. PubMed ID: 28601004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus.
    Lee JH; Teuber G; von Wagner M; Roth WK; Zeuzem S
    J Med Virol; 2000 Mar; 60(3):264-8. PubMed ID: 10630957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual entropy-driven affinity of Chromobacterium violaceum lectin CV-IIL toward fucose and mannose.
    Pokorná M; Cioci G; Perret S; Rebuffet E; Kostlánová N; Adam J; Gilboa-Garber N; Mitchell EP; Imberty A; Wimmerová M
    Biochemistry; 2006 Jun; 45(24):7501-10. PubMed ID: 16768446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
    Seiwert SD; Andrews SW; Jiang Y; Serebryany V; Tan H; Kossen K; Rajagopalan PT; Misialek S; Stevens SK; Stoycheva A; Hong J; Lim SR; Qin X; Rieger R; Condroski KR; Zhang H; Do MG; Lemieux C; Hingorani GP; Hartley DP; Josey JA; Pan L; Beigelman L; Blatt LM
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4432-41. PubMed ID: 18824605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lycorine-derived phenanthridine downregulators of host Hsc70 as potential hepatitis C virus inhibitors.
    Chen D; Cai J; Yin J; Jiang J; Jing C; Zhu Y; Cheng J; Di Y; Zhang Y; Cao M; Li S; Peng Z; Hao X
    Future Med Chem; 2015; 7(5):561-70. PubMed ID: 25921398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering molecular properties and docking studies of hepatitis C and non-hepatitis C antiviral inhibitors - A computational approach.
    Venkatesan A; Febin Prabhu Dass J
    Life Sci; 2017 Apr; 174():8-14. PubMed ID: 28259653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine.
    Meppen M; Pacini B; Bazzo R; Koch U; Leone JF; Koeplinger KA; Rowley M; Altamura S; Di Marco A; Fiore F; Giuliano C; Gonzalez-Paz O; Laufer R; Pucci V; Narjes F; Gardelli C
    Eur J Med Chem; 2009 Sep; 44(9):3765-70. PubMed ID: 19493593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzohydroxamic acids as potent and selective anti-HCV agents.
    Kozlov MV; Kleymenova AA; Romanova LI; Konduktorov KA; Smirnova OA; Prasolov VS; Kochetkov SN
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5936-40. PubMed ID: 24035094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
    Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
    Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry.
    Chung CY; Liu CH; Wang GH; Jassey A; Li CL; Chen L; Yen MH; Lin CC; Lin LT
    Sci Rep; 2016 Jul; 6():29969. PubMed ID: 27426693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
    Guedj J; Neumann AU
    J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.